Format

Send to

Choose Destination
See comment in PubMed Commons below
J Urol. 2003 May;169(5):1706-8.

Defining bacillus Calmette-Guerin refractory superficial bladder tumors.

Author information

  • 1Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Abstract

PURPOSE:

We define bacillus Calmette-Guerin (BCG) refractory, high risk, superficial bladder cancer.

MATERIALS AND METHODS:

A total of 93 patients received a 6-week induction course of BCG. They were evaluated for response after 3 and 6 months. Half of the patients received monthly maintenance BCG for 2 years and half did not. In both groups the initial responses to BCG at 3 and 6 months were correlated with subsequent tumor recurrence and progression.

RESULTS:

Of the 93 cases 57% were negative for tumor at 3 months and 43% had residual tumor resected. At 6 months 80% of the patients were tumor-free and 20% had persistent or recurrent tumor. Maintenance BCG did not decrease tumor recurrence further than induction BCG. Subsequent tumor-free interval during 24 months of followup were best predicted by response to BCG after 6 months.

CONCLUSIONS:

A minimum treatment and followup time of 6 months is required to identify high risk, superficial bladder tumors as truly BCG refractory.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk